Strong sales growth in the first nine months of 2007
- Details
- Category: Roche
![Roche Roche](http://www.worldpharmanews.com/images/stories/logo/roche.gif)
Pfizer Reports Third-Quarter 2007 Results
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Adjusted Diluted EPS of $0.58 for the Third-Quarter 2007 Represents an Increase of 7% Compared to the Same Period a Year Ago.
Novel agent for treatment of cerebral stroke and other diseases with neuronal damage
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Abbott Reports 14.4 Percent Sales Growth in Third Quarter
- Details
- Category: Abbott
![Abbott Abbott](http://www.worldpharmanews.com/images/stories/logo/abbott.gif)
Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
- Details
- Category: Clinical Trials
Pharmion Corporation (Nasdaq: PHRM) today announced the initiation of an international pivotal Phase 3 clinical trial evaluating amrubicin, the Company's third-generation synthetic anthracycline, in the treatment of second-line small cell lung cancer (SCLC). The randomized, controlled, multi-center study will compare amrubicin to topotecan, the only approved chemotherapy for second-line treatment of SCLC in the US and EU. Enrollment in the study of 480 patients is underway.
Three-year analysis demonstrates continued robust treatment effect of Alemtuzumab compared to Rebif
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Bristol-Myers Squibb to Announce Results for the Third Quarter of 2007 on October 25
- Boehringer Ingelheim distinguished as number one Top Employer 2007 by Science Magazine
- Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
- Teva Announces Approval of Generic Actonel®
- EPO Rules European Nexium® Process Patent Valid
- Aptivus® (tipranavir) capsules granted full approval by the U.S. FDA
- Aclasta® receives European approval as first once-yearly treatment for postmenopausal osteoporosis